Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-04

Clinical Trial Update: A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis [Phase 3]

View source ↗

Summary

Phase 3 study of Solosec for treatment of trichomoniasis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOLOSEC (secnidazole)

Snippet

Sponsor: Lupin Research Inc | Conditions: Trichomonas Infection | Phase 3 | Status: COMPLETED | Results posted: 2023-10-04